Multicenter EXCYTE-2 Study to Evaluate the Precision Medicine Platform in Patients With Acute Myeloid Leukemia
Exscientia plc announced the launch of EXCYTE-2, an observational clinical...
Helio Genomics, an AI-driven healthcare company specializing in diagnostics technology and test development for cancer detection, has announced that Gary Frazier has been selected as Chief...
In recent years, the integration of artificial intelligence (AI) has sparked a transformative shift in the way we approach healthcare, disease diagnosis, and drug...
Novel solution distinguishes 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) revealing unprecedented insights into current and future states of disease using one 5ng DNA sample
biomodal, an...
Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., announced plans to launch two critical solutions for oncology research. These automated...
Matica Biotechnology, Inc., a contract development and manufacturing organization (CDMO) of cell and gene therapies (CGTs), announced the appointment of Paul Kim as chief...